Clinical trial
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- March 13, 2025
- Completion date
- March 31, 2035
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary biliary cholangitis (pbc)